Personalised cancer vaccine cuts risk of deadly skin cancer returning by 42% in major trial
Personalised cancer vaccine cuts risk of deadly skin cancer returning by 42% in major trialA personalized cancer vaccine created from the same mRNA technology used for COVID-19 vaccines has shown 42% protection against the return of aggressive skin cancer, bringing hope for a new...
0

0 Comments
Recommended Comments
There are no comments to display.
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.